SCHEMBL3040776

SCHEMBL3040776

O=C/C=C/C(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
TDP1 Q9NUW8 2/20 0.60
MAPK1 P28482 1/20 0.60
MAPT P10636 7/20 0.57
LMNA P02545 3/20 0.57
RECQL P46063 3/20 0.57
PLIN1 O60240 2/20 0.57
PLIN5 Q00G26 2/20 0.57
ABHD5 Q8WTS1 2/20 0.57
BCHE P06276 2/20 0.57
MAOB P27338 2/20 0.57
TNFRSF1A P19438 1/20 0.57
ACHE P22303 1/20 0.57
CYP1B1 Q16678 1/20 0.57
AKT1 P31749 2/20 0.52
RAB9A P51151 4/20 0.52
HPGD P15428 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
NFKB1 P19838 2/20 0.52
NFKB2 Q00653 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3040779 1.00 ALDH1A1 (0.60) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL2954318 0.83 MAPT (0.70) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL11073619 0.83 MAPT (0.70) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL2954324 0.83 MAPT (0.70) ALDH1A1TDP1MAPK1MAPTLMNA
Chalcone SCHEMBL27688124 0.81 CYP1B1 (0.79) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL5119838 0.80 AKT1 (0.61) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL907405 0.80 AKT1 (0.61) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL19209057 0.78 RECQL (0.55) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL19209055 0.78 RECQL (0.55) ALDH1A1TDP1MAPK1MAPTLMNA
SCHEMBL16762594 0.78 ALDH1A1 (0.72) ALDH1A1TDP1MAPTLMNAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7161022-B2 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-01-09 US claimed
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative SANKIO CHEMICAL CO., LTD. (JP) 2005-08-11 US claimed
EP-1505054-A1 PROCESS FOR PRODUCING 4-PHENYL-4-OXO-2-BUTENOIC ESTER DERIVATIVE Sankio Chemical Co., Ltd. (JP) 2005-02-09 EP claimed
US-8501658-B2 Enantioselective reactions catalyzed by chiral triazolium salts THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-08-06 US disclosed
US-8501658-B2 Enantioselective reactions catalyzed by chiral triazolium salts THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-08-06 US disclosed
US-8501658-B2 Enantioselective reactions catalyzed by chiral triazolium salts THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-08-06 US disclosed
US-20100210452-A1 ENANTIOSELECTIVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-08-19 US disclosed
US-20100210452-A1 ENANTIOSELECTIVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-08-19 US disclosed
US-20100210452-A1 ENANTIOSELECTIVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-08-19 US disclosed
WO-2007124494-A2 ENANTIOSELECTVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-11-01 WO disclosed
WO-2007124494-A2 ENANTIOSELECTVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-11-01 WO disclosed
US-7161022-B2 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-01-09 US disclosed
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative SANKIO CHEMICAL CO., LTD. (JP) 2005-08-11 US disclosed
EP-1505054-A1 PROCESS FOR PRODUCING 4-PHENYL-4-OXO-2-BUTENOIC ESTER DERIVATIVE Sankio Chemical Co., Ltd. (JP) 2005-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210452-A1 ENANTIOSELECTIVE REACTIONS CATALYZED BY CHIRAL TRIAZOLIUM SALTS IDH1, MDM4, PCNA ALDH1A1 1165/4885TDP1 3090/4885MAPK1 4195/4885
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative HPD, PAH, CYP4A11 ALDH1A1 1038/4885TDP1 4012/4885MAPK1 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.